These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3639835)

  • 1. [Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation].
    Freise J; Horstkotte H
    Fortschr Med; 1986 Sep; 104(33):625-8. PubMed ID: 3639835
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy with pancreatic enzyme preparations].
    Holtmann G; Layer P
    Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of Creon and Eurobiol in the treatment of exocrine pancreatic insufficiency in adults].
    Emerit J; Levy VG; Paris JC; Quinton A; Sarles H
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):263-7. PubMed ID: 3207353
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversies in the treatment of exocrine pancreatic insufficiency.
    DiMagno EP
    Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B; Ivaldi AP
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic insufficiency in the person with cancer.
    Ropka ME
    Cancer Nurs; 1981 Feb; 4(1):37-41. PubMed ID: 6907047
    [No Abstract]   [Full Text] [Related]  

  • 13. Adsorption of alpha-amylase (EC 3.2.1.1) and lipase (EC 3.1.1.3) before and after substitution therapy in exocrine pancreatic insufficiency.
    Gregar I; Kojecký Z; Matlocha Z
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():233-43. PubMed ID: 2977896
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pancreatic enzyme substitution in patients with mucoviscidosis].
    Henker J
    Gastroenterol J; 1990; 49(4):151-5. PubMed ID: 2184824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts.
    Domínguez-Muñoz JE; Iglesias-García J; Iglesias-Rey M; Vilariño-Insua M
    Gut; 2006 Jul; 55(7):1056-7. PubMed ID: 16766768
    [No Abstract]   [Full Text] [Related]  

  • 17. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Substitution of digestive enzymes in elderly patients].
    Jansen W
    Med Welt; 1982 Sep; 33(37):1281-2. PubMed ID: 6182442
    [No Abstract]   [Full Text] [Related]  

  • 19. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
    Griffin SM; Alderson D; Farndon JR
    Gut; 1989 Jul; 30(7):1012-5. PubMed ID: 2759481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
    Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.